Qigong-Waiqi Healing: Problems of Incorporating into Health Care System

Author: Savva SL
Affiliation: Monterey Institute for the Study of Alternative Healing Arts (MISAHA), Monterey, California, USA
Conference/Journal: 2nd World Congress Qigong
Date published: 1998
Other: Pages: 48 , Word Count: 287

The presented taxonomy of alternative medicine is based on two criteria: the presumed main Native agent and the method of the outcome evaluation. It shows the place of Qigong-Waiqi Healing (QWH) within the realm of alternative and complementary medicine. The core of QWH is psi communication between Master and patient with intent to heal on the part of the healer while techniques (models, actions) may vary widely.

To be accepted by medical community and society an individual Master (healer) must show a statistically significant outcome in a controlled clinical trial on patients with a selected disease/condition (MISAHA developed criteria for selecting model diseases). The result of such trial cannot be extrapolated on other Masters or on a particular technique because it depends on the Master's individual talent and technique.

A positive clinical outcome may have a tremendous scientific value, shedding light on the currently insufficient models of organism's control system, immune system and concepts of pathology. It may show that the key to wellness and cure lies far beyond the level of cellular biochemistry.

The understanding of the artistic nature of QWY leading to the presentation of students based on their natural abilities, is a presupposition for preserving effectiveness of the ancient medical culture, the healing ART, and for the acceptance of QWH by the society.

Organizational difficulties in arranging proper clinical trials are not limited to the lack understanding. One has to 1) obtain a satisfactory proof of the healers efficacy with respect to the selected disease (based on individual clinical records from previous experience), 2) find an enthusiastic medical scientist at a specialized medical facility to be Principal Investigator and 3) persuade the facility to conduct the trial at its expense or find necessary funds for it.